2026 · 3rd Quarter (July 1 - Sep 30)

HEMATOLOGY ONCOLOGY PHARMACY ASSOCIATION

Filed by CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C..

Open official filing

Source-reported fields

Filing overview

Type: 3rd Quarter - Report
Posted: Oct 7, 2026
Income: $50,000.00
Expenses: Not reported
Registrant: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Client: HEMATOLOGY ONCOLOGY PHARMACY ASSOCIATION
Filing UUID: 81a9cfc0-3c6e-49a8-9e78-a6caddf6f18b
Termination date: Not reported

Literal source text

Lobbying issues and bill citations

BUD · Budget/Appropriations

FY27 Labor Health Human Services and Related Agencies; Continuing Resolution

HCR · Health Issues

Cancer Drug Parity Act (H.R. 4101 / S. 5004); Improving Seniors' Timely Access to Care Act (H.R. 3514 / S. 1816); Drug Shortages

Literal federal measure citations: H.R. 4101, S. 5004, H.R. 3514, S. 1816

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.